Jörg Breitenbach

LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX

Formulation Obtained from a Powder Mixture Comprising an Inorganic Pigment

Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same

Pharmaceutical dosage form comprising polymeric carrier composition

Process for producing a solid dispersion of an active ingredient

Process for producing a solid dispersion of an active ingredient

CURCUMINOID SOLID DISPERSION FORMULATION

Self-emulsifying active substance formulation and use of this formulation

Test solvent for evaluating the compatibility of biologically active substances and graft copolymers

Solid Pharmaceutical Dosage Formulation

Delivery system for sustained release of a calcium-channel blocking agent

Self-Emulsifying Active Ingredient Formulation and the Use of this Formulation

Solid pharmaceutical dosage form

Rate-controlled particles

FORMULATION COMPRISING FENOFIBRIC ACID, A PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE THEREOF

Solid pharmaceutical dosage form

PHARMACEUTICAL DOSAGE FORM COMPRISING POLYMERIC CARRIER COMPOSITION

SELF-EMULSIFYING ACTIVE SUBSTANCE FORMULATION AND USE OF THIS FORMULATION

Solubilizing aids in powder form for solid pharmaceutical presentation forms

Solid pharmaceutical dosage form

PHARMACEUTICAL DOSAGE FORM COMPRISING A LIQUID OR FLOWABLE CORE COMPOSITION

Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same

Melt-processed imatinib dosage form

Solid dosage form with a film containing an active substance, as well as its method of production

Nanoparticulate core shell systems and the use thereof in pharmaceutical and cosmetic preparation

PROCESS FOR PRODUCING A SOLID DISPERSION OF AN ACTIVE INGREDIENT

PROCESS FOR PRODUCING A SOLID DISPERSION OF AN ACTIVE INGREDIENT

PRODUCTION OF ENVELOPED PHARMACEUTICAL DOSAGE FORMS

Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix

Production of Dosing Molds from Active Substance-Containing Melts

Production of dosage forms comprising a solid dispersion of a microcrystalline agent

Solid Pharmaceutical Dosage Formulation

Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base

Formulation Obtained From A Powder Mixture Comprising An Inorganic Pigment

SOLID PHARMACEUTICAL DOSAGE FORM

Dosage forms for the delivery of drugs of abuse and related methods

Method for producing water dispersible dry powders from poorly soluble compounds

Method of producing solid shape forms containing an active ingredient

Solid pharmaceutical dosage formulation

Solid pharmaceutical dosage form

Solid pharmaceutical dosage form